Results 91 to 100 of about 14,657 (135)

Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis. [PDF]

Breast Cancer Res Treat
Iwai C, Konishi T, Miyawaki A, Okada A, Isogai T, Jo T, Yasunaga H.   +6 more
europepmc   +1 more source

Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer. [PDF]

Breast
Zecca E, Zambelli L, Tinè G, Bracchi P, Miceli R, Pigni A, Lo Dico S, Ricchini F, Mariani G, Massa G, Caraceni A.   +10 more
europepmc   +1 more source

The impact of photobiomodulation therapy on the survival and differentiation of periodontal ligament mesenchymal stem cells exposed to zoledronic acid. [PDF]

Sci Rep
Etemadi A, Fathizadeh P, Chiniforush N.
europepmc   +1 more source

Successful rapid desensitization to zoledronic acid in a multiple myeloma patient. [PDF]

Discov Oncol
Spataro F, Solimando AG, Desantis V, Vacca A, Ria R.   +4 more
europepmc   +1 more source

Osteoarthritis Flare-up Secondary to Zoledronic Acid Infusion: A Case Report. [PDF]

Oman Med J
Al Kiyumi MH, Al Kiyumi M, Al Harrasi A, Al Saidi Y, Al Sumri H, Al Shidhani A, Al Sumri S, Al Mahrezi A.   +7 more
europepmc   +1 more source

Preliminary Data From a Geriatrician-Led Program for Orthopedic Co-Managed Hip Fracture Patients Using Zoledronic Acid. [PDF]

J Am Geriatr Soc
Chahal K, Nguyen J, Rajesh D, McBroom T, T Wagner K, McTague M, Lipsitz L, Rodriguez EK, Wixted J, Berry SD.   +9 more
europepmc   +1 more source

Bisphosphonate Use in Acute Spinal Cord Injury: A Focused Systematic Review on Zoledronic Acid. [PDF]

Cureus
Mun S, Chalasani R, Van de Vel G, Shukla PS, Zia SUD, Mohammed L.   +5 more
europepmc   +1 more source

24-hour urinary creatinine as a predictor of lumbar spine bone mineral density change after one-year of zoledronic acid treatment in older postmenopausal women with osteoporosis: a cohort study. [PDF]

BMC Geriatr
Zeng J, Jing Y, Li N, Ge J, Ma H, Sun S, Qian C, Cui R, Qu S, Sheng H.   +9 more
europepmc   +1 more source

Estrogen prevents anti-tumor effects of Zoledronic acid in breast cancer through the NK and CD8+T cell PD-1/PD-L1 axes

George C, Zhou J, Canuas-Landero V, Lefley D, Hughes R, Thistletwaite F, Wilson C, Holen I, Brown J, Dunning M, Danson S, Winter M, Quayle L, Muthana M, Ottewell P.   +14 more
europepmc   +1 more source